# Efficacy and Safety of Botulinum Toxin A for the Treatment of Refractory Overactive Bladder.

> **NCT00231491** · PHASE2 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 160 (actual)

## Conditions studied

- Overactive Bladder

## Interventions

- **DRUG:** Botulinum Toxin A (Botox )

## Key facts

- **NCT ID:** NCT00231491
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2011-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00231491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00231491, "Efficacy and Safety of Botulinum Toxin A for the Treatment of Refractory Overactive Bladder.". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00231491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*